Covid-19 Impact on In-Vitro Diagnostic Market CAGR Rapidly Growing in Coming Yea

1. In Vitro Diagnostic Market To Exhibit CAGR of 6.6% during 2020-2030 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The in vitro diagnostic (IVD) market had a size of $63.5 billion in 2019, and it will demonstrate a CAGR of 6.6% in the coming years. The market is further expected to generate revenue of $127.4 billion in 2030. The key factors driving this growth are the advancements in the IVD technology, growth in the number of hospitals and academic institutions, increase in healthcare expenditure, and strict legislations related to blood safety and prevention of sample contamination. In this regard, the escalating number of blood donors is aiding the in vitro diagnostic market advance. As per the WHO, 118.4 million units of blood were donated in 2018, and this increasing count is boosting the market advance. It was also reported that nearly 106 million blood donations are made globally and almost 13,300 blood centers exist in 169 countries presently. Before the donated blood is transfused, checking for infections or mutated genes is necessary. This is done via a range of IVD tests, thus propelling the market. The rising chronic disease cases are also leading to the growth of the in vitro diagnostic market. The WHO reported that in 2018, there were 9.6 million deaths due to cancer. Moreover, as per the Joint United Nations Programme on HIV/AIDS (UNAIDS), there were around 37.9 million people with HIV in 2018. To monitor the progress of people affected by such chronic diseases, diagnostic tests need to be conducted regularly, which is driving the demand for the various products used in IVD. Among the various categories within the offering segment of the in vitro diagnostic market, reagents & kits has been dominating the market, due to the increment in the volume of laboratory tests. The rising incidence of chronic and acute diseases is driving the demand for IVD tests, which is propelling the consumption of reagents and kits, which are consumables, therefore need to be restocked regularly. Moreover, the increase in the usage of such products in research and introduction of new reagents and kits globally are thrusting the market. To receive free sample pages of this report @ https://www.psmarketresearch.com/market-analysis/in-vitro- diagnostic-market/report-sample On the basis of application, the infectious diseases category is set to generate the highest revenue in future. Infectious diseases are caused by fungi, parasites, bacteria, and virus, and they can spread via direct and indirect contact, which is a key reason behind the soaring cases of COVID-19. Therefore, with other infectious diseases, such as influenza, malaria, dengue, HIV/AIDS, chickenpox, polio, E. coli, and cowpox, also rising in incidence, the volume of IVD tests is surging. 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. North America is expected to continue to be the largest in vitro diagnostic market till 2030. The key factors responsible for this are the rise in the healthcare expenditure and increment in research and development activities. Asia-Pacific is projected to record the fastest growth in the coming years due to the presence of key market players and their strategic developments. APAC is the most-populated region in the world and also the one with a relatively lower access to quality healthcare than the developed world, which results in a huge patient pool. Hence, in the coming years, the market will boom because of the increasing number of people with infectious diseases and rising volume of blood being donated. The research offers market size of the global in vitro diagnostics (IVD) market for the period 2014–2030. Market Segmentation by Offering Reagents & Kits Instruments Software & Services Market Segmentation by Technology    Clinical Chemistry  oBasic metabolic panel oLipid profile oLiver profile oRenal profile oThyroid function panel oOthers  Immunochemistry oEnzyme-linked immunosorbent assay (ELISA) oRadioimmunoassay (RIA) oFluoroimmunoassay (FIA) oChemiluminescence immunoassay (CLIA) oImmunochromatographic Assay (ICA) oOthers  Molecular Diagnostics oInfectious diseases 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. oGenomics oBlood donor screening oOthers  Hematology oComplete blood count (CBC) oCholesterol testing oBlood glucose testing oHemoglobin testing oCoagulation testing oOthers  Microbiology Others Market Segmentation by Application  Infectious Diseases Diabetes Oncology Cardiology Nephrology Autoimmune Diseases Others Market Segmentation by End User        Hospitals & Clinics Point of Care (POC) Laboratories Research & Academic Institutes Market Segmentation by Region     North America IVD Market  oBy offering oBy technology oBy application oBy end user oBy country – U.S. and Canada U.S. IVD market By offering   4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. By technology By application By end user Canada IVD market By offering By technology By application By end user Europe IVD Market          oBy offering oBy technology oBy application oBy end user oBy country – Germany, France, U.K., Spain, Italy, and Rest of Europe Germany IVD market By offering By technology By application By end user France IVD market By offering By technology By application By end user U.K. IVD market By offering By technology By application By end user Spain IVD market By offering By technology By application By end user Italy IVD market By offering                       5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

6. By technology By application By end user Asia-Pacific (APAC) IVD Market     oBy offering oBy technology oBy application oBy end user oBy country – China, Japan, India, and Rest of APAC China IVD market By offering By technology By application By end user Japan IVD market By offering By technology By application By end user India IVD market By offering By technology By application By end user Latin America (LATAM) IVD Market                 oBy offering oBy technology oBy application oBy end user oBy country – Mexico, Brazil, and Rest of LATAM Mexico IVD market By offering By technology By application By end user Brazil IVD market       6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

7. By offering By technology By application By end user Middle East & Africa (MEA) IVD Market      oBy offering oBy technology oBy application oBy end user oBy country – Saudi Arabia, South Africa, and Rest of MEA South Africa IVD market By offering By technology By application By end user Saudi Arabia IVD market By offering By technology By application By end user           7 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

8. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 8 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved